- Release Date: 26/11/15 11:20
- Summary: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
- Price Sensitive: No
- Download Document 664B
BLT 26/11/2015 11:20 GENERAL NOT PRICE SENSITIVE REL: 1120 HRS BLIS Technologies Limited GENERAL: BLT: Preliminary Results for BLIS probiotic trial Preliminary results from a field trial in the Eastern Bay of Plenty using BLIS K12 probiotic presented to the Paediatric Society of New Zealand yesterday indicated that a one month course of BLIS K12 probiotic achieves a useful, greater decrease in both Group A Streptococcal (GAS) carriage and GAS sore throats than antibiotics alone. Further analysis of the results are being undertaken and presented early next year. Peter Fennessy Chairman End CA:00274150 For:BLT Type:GENERAL Time:2015-11-26 11:20:37
- Forums
- NZX - By Stock
- BLT
- Ann: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
Ann: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
Featured News
Add BLT (NZSX) to my watchlist